Charles R. Dean - Concepedia

Author

Charles R. Dean

Novartis (United States)ORCID

Also Known As

C Dean, C R Dean, C. R. Dean, Charles Dean, Charles R. Dean, Dean, Charles R.

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Novartis (Switzerland)Novartis Institutes for BioMedical Research Queen's University University of Virginia

About

Charles R. Dean is an author at Novartis (United States) specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	22	1.8K
2	Natural Sciences	9	9	551
3	Health Sciences	5	5	659
4	Engineering	2	2	59
5	Allergy	1	1	159

Charles R. Dean

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Efflux-Mediated Resistance to Tigecycline (GAR-936) in <i>Pseudomonas aeruginosa</i> PAO1 Charles R. Dean, M Visalli, Steven J. Projan, Antimicrobial Agents and Chemotherapy BacteriologyAntibiotic ResistanceBacterial PathogensEfflux-mediated ResistanceDrug Resistance	2003	281
<i>Pseudomonas aeruginosa</i>Increases Formation of Multidrug-Tolerant Persister Cells in Response to Quorum-Sensing Signaling Molecules Nina Möker, Charles R. Dean, Jianshi Tao Journal of Bacteriology Microbial PathogensBacteriologyMicrobial PhysiologyPersister FormationAntibiotic Resistance	2010	238
IL-1RL2 and Its Ligands Contribute to the Cytokine Network in Psoriasis Hal Blumberg, Huyen Dinh, Charles R. Dean, The Journal of Immunology Il-1 Family MemberImmune RegulationImmunologyInnate ImmunityDermatology	2010	159
<i>mexEF-oprN</i> Multidrug Efflux Operon of <i>Pseudomonas aeruginosa</i> : Regulation by the MexT Activator in Response to Nitrosative Stress and Chloramphenicol Hossam Fetar, C. M. Gilmour, Rachael Klinoski, Antimicrobial Agents and Chemotherapy BacteriologyMolecular BiologyBacterial PathogensRedox BiologyDrug Resistance	2010	136
Cloning and characterization of the ferric enterobactin receptor gene (pfeA) of Pseudomonas aeruginosa Charles R. Dean, Keith Poole Journal of Bacteriology BiochemistryOuter MembraneVirulence FactorPathogenesisBacteriology	1993	109
Expression of the ferric enterobactin receptor (PfeA) of <i>Pseudomonas aeruginosa</i>: involvement of a two‐component regulatory system Charles R. Dean, Keith Poole Molecular Microbiology Two‐component Regulatory SystemMicrobial PathogensBiochemistryStructural GenePfer Mutant	1993	95
PfeR, an enterobactin-responsive activator of ferric enterobactin receptor gene expression in Pseudomonas aeruginosa Charles R. Dean, Shádi Neshat, Keith Poole Journal of Bacteriology Pfer Knockout MutantAntimicrobial Resistance GeneBiochemistryEnterobactin-responsive ActivatorNatural Sciences	1996	84
<i>Pseudomonas aeruginosa galU</i>is required for a complete lipopolysaccharide core and repairs a secondary mutation in a PA103 (serogroup O11)<i>wbpM</i>mutant Charles R. Dean, Joanna B. Goldberg FEMS Microbiology Letters BacteriologyBacteriophageMolecular BiologyWbpm GeneBacterial Pathogens	2002	82
The <i>galU</i> Gene of <i>Pseudomonas aeruginosa</i> Is Required for Corneal Infection and Efficient Systemic Spread following Pneumonia but Not for Infection Confined to the Lung Gregory P. Priebe, Charles R. Dean, Tanweer Zaidi, Infection and Immunity Pathogenic MicrobiologyMicrobial PathogensBacteriologyImmunologyPathology	2004	79
Characterization of an Acinetobacter baumannii <i>lptD</i> Deletion Strain: Permeability Defects and Response to Inhibition of Lipopolysaccharide and Fatty Acid Biosynthesis Jade Bojkovic, Daryl L. Richie, David A. Six, Journal of Bacteriology	2015	79

Page 1